Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0002736 (
amyotrophic lateral sclerosis
)
19,048
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Disruption of endoplasmic reticulum (ER) proteostasis is a salient feature of
amyotrophic lateral sclerosis
(
ALS
). Upregulation of ER foldases of the protein disulfide isomerase (PDI) family has been reported in
ALS
mouse models and spinal cord tissue and body fluids derived from sporadic
ALS
cases. Although in vitro studies suggest a neuroprotective role of PDIs in
ALS
, the possible contribution of genetic mutations of these ER foldases in the disease process remains unknown. Interestingly, intronic variants of the
PDIA1
gene were recently reported as a risk factor for
ALS
. Here, we initially screened for mutations in two major PDI genes (
PDIA1
/P4HB and PDIA3/ERp57) in a US cohort of 96 familial and 96 sporadic
ALS
patients using direct DNA sequencing. Then, 463 familial and 445 sporadic
ALS
patients from two independent cohorts were also screened for mutations in these two genes using whole exome sequencing. A total of nine
PDIA1
missense variants and seven PDIA3 missense variants were identified in 16
ALS
patients. We have identified several novel and rare single nucleotide polymorphisms (SNPs) in both genes that are enriched in
ALS
cases compared with a large group of control subjects showing a frequency of around 1% in
ALS
cases. The possible biological and structural impact of these
ALS
-linked PDI variants is also discussed.
...
PMID:Identification of rare protein disulfide isomerase gene variants in amyotrophic lateral sclerosis patients. 2591 42
Disturbance of endoplasmic reticulum (ER) proteostasis is a common feature of
amyotrophic lateral sclerosis
(
ALS
). Protein disulfide isomerases (PDIs) areERfoldases identified as possibleALSbiomarkers, as well as neuroprotective factors. However, no functional studies have addressed their impact on the disease process. Here, we functionally characterized fourALS-linked mutations recently identified in two majorPDIgenes,
PDIA1
andPDIA3/ERp57. Phenotypic screening in zebrafish revealed that the expression of thesePDIvariants induce motor defects associated with a disruption of motoneuron connectivity. Similarly, the expression of mutantPDIs impaired dendritic outgrowth in motoneuron cell culture models. Cellular and biochemical studies identified distinct molecular defects underlying the pathogenicity of thesePDImutants. Finally, targetingERp57 in the nervous system led to severe motor dysfunction in mice associated with a loss of neuromuscular synapses. This study identifiesERproteostasis imbalance as a risk factor forALS, driving initial stages of the disease.
...
PMID:ALS-linked protein disulfide isomerase variants cause motor dysfunction. 2696 85
Amyotrophic lateral sclerosis
(
ALS
) is a fatal neurodegenerative disorder and mutations in superoxide dismutase 1 (SOD1) account for 20% of familial
ALS
cases. The aetiology of
ALS
remains unclear, but protein misfolding, endoplasmic reticulum (ER) stress and neuronal apoptosis are implicated. We previously established that protein disulphide isomerase (
PDIA1
) is protective against ER stress and apoptosis in neuronal cells expressing mutant SOD1, and recently mutations in
PDIA1
and related PDI family member endoplasmic reticulum protein 57 (ERp57/PDIA3), were associated with
ALS
. Here, we examined whether ERp57 is also protective against mutant SOD1 or whether distinct specificity exists amongst individual PDI family members. Neuronal cells co-expressing SOD1 and ERp57 were examined for inclusion formation, ER stress, ubiquitin proteasome system (UPS) dysfunction and apoptosis. Over-expression of ERp57 inhibited inclusion formation, ER stress, UPS dysfunction and apoptosis, whereas silencing of ERp57 expression enhanced mutant SOD1 inclusion formation, ER stress and toxicity, indicating a protective role for ERp57 against SOD1 misfolding. ERp57 also inhibited the formation of mutant SOD1 inclusions and apoptosis in primary cortical neurons, thus confirming results obtained from cell lines. ERp57 partially co-localized with TAR DNA-binding protein-43 (TDP-43)-positive inclusions in spinal cords from sporadic
ALS
patients, thus linking ERp57 to protein misfolding in human sporadic disease. Our results therefore imply that ERp57 has a protective role against pathological events induced by mutant SOD1 and they link ERp57 to the misfolding of TDP-43. This study therefore has implications for the design of novel therapeutics based on the activities of the PDI family of proteins.
...
PMID:ERp57 is protective against mutant SOD1-induced cellular pathology in amyotrophic lateral sclerosis. 2940 23